SWITCHING FROM AN INTENSIFIED REGIMEN OF INFLIXIMAB TO A SUBCUTANEOUS STANDARD DOSE IN ADULTS WITH INFLAMMATORY BOWEL DISEASE: OUR EXPERIENCE IN A TERTIARY HOSPITAL

Irene Chivato Martín-Falquina  ¹     Blanca Vicente González  ²     Lara Arias-García     Natalia Revilla Cuesta     ROSA MARIA SAIZ CHUMILLAS     Beatriz Sicilia Aladrén  ^3    
1 Hospital Universitario Burgos, Burgos, Spain
² Hospital Universitario de Burgos, Burgos, Spain
³ H Universitario de Burgos, Burgos, Spain

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)